3 Top Value Plays for Long-Term Investors

Looking for a value play? If so, National Bank of Canada (TSX:NA), Cameco Corporation (TSX:CCO)(NYSE:CCJ), and Concordia Healthcare Corp. (TSX:CXR)(NASDAQ:CXRX) are great options.

| More on:
The Motley Fool

If you’re looking to add a value-based investment to your portfolio, you’ve come to the right place. I’ve scoured the market and found three stocks from three different industries that are trading at inexpensive valuations compared with their five-year and industry averages, so let’s take a quick look to determine if one or more of them could fulfill your portfolio’s needs.

1. National Bank of Canada

National Bank of Canada (TSX:NA) is Canada’s sixth-largest bank with approximately $216.1 billion in total assets.

At today’s levels, its stock trades at just 8.6 times fiscal 2016’s estimated earnings per share of $4.76 and only 8.1 times fiscal 2017’s estimated earnings per share of $5.05, both of which are inexpensive compared with its five-year average price-to-earnings multiple of 10.1 and its industry average multiple of 12.9.

At the very least, I think National Bank’s stock should trade at 10 times earnings, which would place its shares upwards of $50 by the conclusion of fiscal 2017, representing upside of more than 22% from current levels.

Also, the company pays a quarterly dividend of $0.54 per share, or $2.16 per share annually, giving its stock a 5.3% yield.

2. Cameco Corporation

Cameco Corporation (TSX:CCO)(NYSE:CCJ) is one of the world’s largest producers of uranium, providing about 16% of the world’s total production, and it is one of the leading providers of nuclear fuel processing services.

At today’s levels, its stock trades at just 16.5 times fiscal 2015’s estimated earnings per share of $1.05 and only 12.9 times fiscal 2016’s estimated earnings per share of $1.34, both of which are inexpensive compared with its five-year average price-to-earnings multiple of 100.8 and its industry average multiple of 21.7.

At the very least, I think Cameco’s stock should trade at 18 times earnings, which would place its shares upwards of $24 by the conclusion of fiscal 2016, representing upside of more than 38% from current levels.

In addition, the company pays a quarterly dividend of $0.10 per share, or $0.40 per share annually, giving its stock a 2.3% yield. 

3. Concordia Healthcare Corp.

(All figures are in U.S. dollars)

Concordia Healthcare Corp. (TSX:CXR)(NASDAQ:CXRX) is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs.

At today’s levels, its stock trades at just 8.7 times fiscal 2015’s estimated earnings per share of $4.50 and a mere 6.2 times fiscal 2016’s estimated earnings per share of $6.37, both of which are inexpensive compared with its five-year average price-to-earnings multiple of 149.3 and its industry average multiple of 31.2.

At the very last, I think Concordia’s stock should trade at eight times earnings, which would place its shares around $51 by the conclusion of fiscal 2016, representing upside of more than 30% from current levels.

Also, the company pays a quarterly dividend of $0.075 per share, or $0.30 per share annually, giving its stock a 0.8% yield.

Should one of these stocks be atop your buy list?

National Bank of Canada, Cameco, and Concordia Healthcare are three of the top value plays in their respective industries. Foolish investors should strongly consider establishing positions in one of them today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joseph Solitro has no position in any stocks mentioned.

More on Investing

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

young woman celebrating a victory while working with mobile phone in the office
Investing

3 Roaring Stocks to Hold for the Next 20 Years

These top TSX stocks are excellent long-term buys, given their multi-year growth potential and solid underlying businesses.

Read more »

Two seniors float in a pool.
Dividend Stocks

TFSA: How to Earn $1,890 in Annual Tax-Free Income

Plunk these investments into your TFSA to earn passive income and avoid the taxman.

Read more »

grow dividends
Investing

Here’s My Top 3 TSX Stocks to Buy Right Now

Even though the TSX has been rising, there are still some good bargains out there. Here are three top compounding…

Read more »

Target. Stand out from the crowd
Investing

Prediction: This Canadian Growth Stock Could Double by 2030

Alimentation Couche-Tard (TSX:ATD) is a top growth stock that could do well over the next six or so years.

Read more »

Businessman holding AI cloud
Tech Stocks

Could Investing $20,000 in Nvidia Make You a Millionaire?

Nvidia stock has made investors millionaires in the last 10 years. Is it too late to invest to become a…

Read more »

Engineers walk through a facility.
Dividend Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

AtkinsRéalis (TSX:ATRL) is one TSX stock I'd never invest in.

Read more »

money cash dividends
Stocks for Beginners

Have $500? 3 Absurdly Cheap Stocks Long-Term Investors Should Buy Right Now

If you're looking for cheap stocks, these three have a huge future ahead of them, all while costing far less…

Read more »